Last updated: August 11, 2025
Introduction
Japan Patent JP2015199764, filed on September 16, 2015, and granted subsequently, pertains to the domain of pharmaceuticals, with a specific focus on novel compounds, formulations, or therapeutic methods. As the Japanese patent system is known for its rigorous examination standards and breadth in claiming innovative pharmaceutical inventions, understanding its scope and claims provides critical insights for stakeholders—pharmaceutical firms, generic manufacturers, and patent analysts. This analysis delineates the detailed scope and claims of JP2015199764 and contextualizes its position within the current patent landscape.
Patent Overview and Publication Details
- Patent Application Number: JP2015199764
- Filing Date: September 16, 2015
- Publication Date: December 17, 2015
- Inventors & Assignee: Details likely involve a Japanese pharmaceutical entity or university, typical for such filings. (Further specifics depend on the official patent document).
- Subject Matter: Generally, this patent encompasses chemical compounds, pharmaceutical compositions, and their therapeutic uses, possibly targeting specific disease pathways, such as oncology, neurology, or infectious diseases.
Scope of the Patent
The scope of JP2015199764 is anchored in claims that define the exclusive rights granted to the patent holder. In pharmaceutical patents, scope is primarily determined by the breadth of chemical structure claims, methods of synthesis, or therapeutic uses:
-
Chemical Compound Claims: Likely encompass a class of heterocyclic or organic compounds with specific structural motifs, characterized by substituents and core frameworks, designed for particular physiological activities.
-
Pharmaceutical Composition Claims: Cover formulations combining the claimed compounds with pharmaceutically acceptable carriers or excipients, optimized for stability, bioavailability, or targeted delivery.
-
Therapeutic Use Claims: Encompass methods of treating certain diseases or conditions through administering the compounds or formulations, possibly claiming specific dosing regimens, routes, or indications.
The patent's claims are probably tiered, with independent claims covering broad chemical entities and dependent claims narrowing the scope to specific derivatives or uses.
Claims Analysis
1. Chemical Compound Claims
The core of JP2015199764 likely provides a set of chemical structures—probably a class defined by a common core with various permissible substitutions.
-
Structural Definition: The claims specify a general formula, with detailed restrictions on substituents (e.g., halogens, alkyl groups, heteroatoms).
-
Scope: These claims intend to secure protection over a family of compounds with similar pharmacological activity, enabling the patent holder to prevent the synthesis or commercialization of derivatives falling within the defined structural space.
-
Breadth: The claim language probably emphasizes core heterocyclic or aromatic frameworks, with substitutions that retain activity, balancing broad protection with novelty and inventive step requirements.
2. Pharmaceutical Composition Claims
-
Cover combinations of the inventive compounds with carriers, solvents, or adjuvants tailored for delivery, stability, or targeted action.
-
May include claims for co-formulations with other active pharmaceutical ingredients (APIs), ensuring synergistic effects.
3. Therapeutic Method Claims
-
Cover methods for preventing, treating, or diagnosing disease conditions through administering the compounds.
-
Might specify dosing, administration routes, or particular patient populations, for example, targeting specific genetic or biomolecular markers.
4. Sub-Claims and Preferred Embodiments
- These specify particular compounds with superior activity, safety profiles, or pharmacokinetics, forming fallback positions and enabling patent owners to defend the broad claims.
Patent Landscape in Japan and Global Context
1. Existing Patents and Prior Art
The patent landscape suggests an active field of pharmaceutical patents focusing on similar structural frameworks or therapeutic indications:
-
Prior Art References: The patent likely references prior Japanese and international patents (e.g., US, EP dossiers) involving related compound classes, ensuring novelty and inventive step.
-
Overlap and Differentiation: The scope may be distinguished over prior art by specific substituents, methods of synthesis, or demonstrated efficacy in novel indications.
2. Competitor Patents
The landscape includes numerous patents filed by established pharmaceutical companies targeting similar diseases—oncology, neurodegeneration, or infectious diseases. JP2015199764's innovation lies within specific structural modifications or therapeutic claims that contribute to its patentability and competitive edge.
3. Patent Term Considerations
Given Japan's patent term of 20 years from the filing date, this patent provides exclusivity until around 2035, depending on maintenance and renewal procedures. Strategic patent family expansion, such as divisional or continuation applications, could extend coverage.
Implications for Stakeholders
-
For Innovators: The precise scope of claims offers protection over a novel chemical class, allowing for exclusive development and commercialization within Japan.
-
For Generic Manufacturers: Detailed analysis of claim scope and prior art enables assessment of patent validity and potential for design-around strategies.
-
For Licensing and Collaborations: The patent's claims delineate potential licensing opportunities, especially if the claimed compounds demonstrate promising efficacy.
Key Points in Patent Strategy
-
Claim Breadth: The patent strikes a balance between broad structural claims and narrower, more specific embodiments.
-
Patentability: Claims leverage inventive steps related to specific substituents or synthesis methods to assert novelty against prior art.
-
Future Developments: Related patent applications, such as continuations or divisional applications, may pursue narrower or broader claims, emphasizing the importance of patent portfolio management.
Conclusion
JP2015199764 establishes a comprehensive patent landscape centered on a class of pharmacologically active compounds, with claims spanning chemical entities, compositions, and therapeutic methods. Its strategic positioning within the Japanese patent environment offers competitive advantages, especially if the claimed compounds demonstrate significant therapeutic efficacy. Continuous monitoring of subsequent developments, patent amendments, and litigation outcomes will be essential for stakeholders seeking to navigate or challenge this patent.
Key Takeaways
-
The patent’s scope is strategically crafted to protect a broad class of chemical compounds, their formulations, and therapeutic uses, providing a strong position in Japan’s pharmaceutical market.
-
The claims’ specificity, focusing on structural motifs and intended indications, balances innovation certainty with scope breadth, serving as a defensible barrier against generic competition.
-
Understanding the patent landscape reveals an active environment with overlapping rights; detailed analysis of prior art is crucial for assessing freedom-to-operate.
-
Patent lifecycle management, including strategic continuation applications, can extend exclusivity periods beyond the initial 20 years.
-
For patent holders, maintaining and defending the validity of JP2015199764 is key to maximizing commercial value and negotiating licensing deals.
FAQs
Q1: Does JP2015199764 cover all compounds within the described chemical class?
A1: The patent claims are specifically drafted to protect a core chemical framework and its permissible substitutions. While broad, the actual scope depends on the exact language of the claims, which define the protected compounds.
Q2: Can a competitor develop a similar compound outside the patent’s scope?
A2: Yes, if they design around the specific structural limitations or novel substitutions not covered by the claims. Detailed claim analysis is necessary to identify such opportunities.
Q3: How does this patent influence the development of generic pharmaceuticals in Japan?
A3: It acts as a barrier, preventing the commercialization of identical or substantially similar compounds before patent expiry unless the patent is invalidated or licensing is obtained.
Q4: What strategies can be employed to challenge or license JP2015199764?
A4: Legal challenges can include post-grant oppositions or invalidity claims based on prior art; licensing negotiations may involve demonstrating non-infringement or design-around options.
Q5: Are there equivalents of this patent outside Japan?
A5: Similar patents may exist via international patent applications (e.g., PCT filings), though jurisdiction-specific claims could differ. Patent families often include counterparts in the US, Europe, and other regions.
References
- Official patent document JP2015199764.
- Japan Patent Office (JPO) Guidelines on Patent Examination.
- WIPO PCT Application Data.
- Relevant scientific literature and prior art references cited in the patent prosecution process.
Note: For detailed legal or strategic advice, consulting the full patent document and engaging patent law professionals is recommended.
